Eloxx Pharmaceuticals, Inc. (ELOX)

USD 0.0

(0.0%)

Eps Summary of Eloxx Pharmaceuticals, Inc.

  • Eloxx Pharmaceuticals, Inc.'s latest annual eps in 2022 was -16.65 USD , up 56.36% from previous year.
  • Eloxx Pharmaceuticals, Inc.'s latest quarterly eps in 2023 Q3 was -1.31 USD , up 33.16% from previous quarter.
  • Eloxx Pharmaceuticals, Inc. reported an annual eps of -38.15 USD in 2021, down -10.68% from previous year.
  • Eloxx Pharmaceuticals, Inc. reported an annual eps of -34.47 USD in 2020, up 35.52% from previous year.
  • Eloxx Pharmaceuticals, Inc. reported a quarterly eps of -1.31 USD for 2023 Q3, up 33.16% from previous quarter.
  • Eloxx Pharmaceuticals, Inc. reported a quarterly eps of -2.88 USD for 2023 Q1, up 1.37% from previous quarter.

Annual Eps Chart of Eloxx Pharmaceuticals, Inc. (2022 - 1996)

Historical Annual Eps of Eloxx Pharmaceuticals, Inc. (2022 - 1996)

Year Eps Eps Growth
2022 -16.65 USD 56.36%
2021 -38.15 USD -10.68%
2020 -34.47 USD 35.52%
2019 -53.46 USD 8.13%
2018 -58.19 USD 65.87%
2017 -170.52 USD 14.62%
2016 -199.71 USD 38.64%
2015 -325.47 USD 67.53%
2014 -1002.37 USD 25.63%
2013 -1347.73 USD 62.42%
2012 -3586.73 USD 24.18%
2011 -4730.28 USD 36.75%
2010 -7478.37 USD 65.02%
2009 -21.37 Thousand USD 7.79%
2008 -23.18 Thousand USD -14.88%
2007 -20.18 Thousand USD -35.3%
2006 -14.91 Thousand USD 13.16%
2005 -17.17 Thousand USD -11.28%
2004 -15.43 Thousand USD 29.18%
2003 -21.79 Thousand USD -56.11%
2002 -13.96 Thousand USD -6.54%
2001 -13.1 Thousand USD 31.58%
2000 -19.15 Thousand USD 23.23%
1999 -24.94 Thousand USD -3707.3%
1998 -655.27 USD -386.36%
1997 -134.73 USD -32.83%
1996 -101.43 USD 0.0%

Peer Eps Comparison of Eloxx Pharmaceuticals, Inc.

Name Eps Eps Difference
America Great Health - USD Infinity%
Ampio Pharmaceuticals, Inc. -10.67 USD -56.045%
Aridis Pharmaceuticals, Inc. -1.64 USD -915.244%
Biora Therapeutics, Inc. -7.87 USD -111.563%
Bio-Path Holdings, Inc. -33.64 USD 50.505%
Better Therapeutics, Inc. -1.69 USD -885.207%
Calithera Biosciences, Inc. -7.94 USD -109.698%
Comera Life Sciences Holdings, Inc. -1.76 USD -846.023%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -16.37 USD -1.71%
Evelo Biosciences, Inc. -26.28 USD 36.644%
Evolutionary Genomics, Inc. -0.35 USD -4657.143%
Finch Therapeutics Group, Inc. -46.59 USD 64.263%
Galera Therapeutics, Inc. -1.33 USD -1151.88%
Innovation1 Biotech Inc. -0.70 USD -2278.571%
Kiromic BioPharma, Inc. -21.41 USD 22.233%
Molecular Templates, Inc. -1.80 USD -825.0%
Navidea Biopharmaceuticals, Inc. -0.59 USD -2722.034%
NexImmune, Inc. -30.82 USD 45.977%
Orgenesis Inc. -1.91 USD -771.728%
Panbela Therapeutics, Inc. -232.42 Thousand USD 99.993%
Point of Care Nano-Technology, Inc. -0.10 USD -16550.0%
PaxMedica, Inc. Common Stock -11.00 USD -51.364%
Scopus BioPharma Inc. -0.55 USD -2927.273%
Sorrento Therapeutics, Inc. -1.37 USD -1115.328%
Statera Biopharma, Inc. -4.97 USD -235.01%
TRACON Pharmaceuticals, Inc. -2.20 USD -656.818%
Trevena, Inc. -54.51 USD 69.455%
Vaxxinity, Inc. -0.45 USD -3600.0%
Vaccinex, Inc. -43.68 USD 61.882%
Vicapsys Life Sciences, Inc. -0.03 USD -48584.211%
Viracta Therapeutics, Inc. -1.32 USD -1161.364%
ZIVO Bioscience, Inc. -4.60 USD -261.957%